ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
2026-02-13
$76.70
+1.6 ( 2.13% )
Pricing delayed by 20 minutes
Last updated
2026-02-24 16:00:00